To help people with type 1 diabetes and their families live better lives.
Learns and adjusts according to your insulin needs, whilst giving you the freedom to change settings.
Compatible with the Android OS.*
*Android is a trademark of Google LLC
Approved for ages one year and over.
Developed at the University of Cambridge. Considered by many as "the best algorithm out there."
Randomised clinical trials have shown a significant increase in time in range, a reduction in HbA1c, as well as a reduction in time spent in hypoglycaemia and hyperglycaemia and improved well-being.
Review of the CamAPS FX app performance, functionality, and the information within the app is carried out at least every six months.
I have full trust in the CamAPS FX app and I feel like for the first time since the diagnosis I can relax. Without a doubt, the time Sofia-Stevie spends within her target blood glucose range has improved.
Read moreIt is amazing how much treatment has changed since I was diagnosed. I really feel like I’ve come from the desert into the digital world. To anyone considering the CamAPS FX app, my advice is quite simple: go for it. It really is transformational; and if I can do it, anyone can.
Read moreCamAPS FX is a mobile app to manage glucose levels in people with type 1 diabetes, aged one year and older, using an advanced adaptive hybrid closed-loop approach.
Find out more
Ypsomed, together with CamDiab, is launching the iOS version for the mylife CamAPS FX app, which is part of the automated insulin delivery system mylife Loop.
Download
CamDiab secures FDA approval for advanced adaptive hybrid closed-loop app CamAPS FX.
Download
Ypsomed and CamDiab launch the first system for automated insulin dosing with Abbott’s FreeStyle Libre 3.
Download
Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes.
Download
Ypsomed partners with CamDiab Ltd to drive on smartphone based adaptive automated insulin delivery (AID).
Download